Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Stadler

Showing results (121-130 of 229) with videos related to

Pageof 23
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|April 11, 2014
Neoadjuvant chemotherapy first, followed by chemoradiation and then surgery, in the management of locally advanced rectal cancerAndrea Cercek, Karyn A Goodman, Carla Hajj, et al.
The American Journal of Gastroenterology|February 27, 2025
Neoplasia Detection Through Colonic Surveillance Among Young Individuals With MSH6 / PMS2 -Associated Lynch SyndromeAlicia Latham, Ying L Liu, Gillain Constantino, et al.
Familial Cancer|October 10, 2024
MSH6-proficient crypt foci in MSH6 constitutional mismatch repair deficiency: reversion of a frameshifted coding microsatellite to its wild-type sequenceJinru Shia, Francisco Sanchez-Vega, Stanley Cho, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 8, 2018
Determining the clinical validity of hereditary colorectal cancer and polyposis susceptibility genes using the Clinical Genome Resource Clinical Validity FrameworkBryce A Seifert, Jennifer L McGlaughon, Sarah A Jackson, et al.
Cancer|January 9, 2019
Ampullary cancer: Evaluation of somatic and germline genetic alterations and association with clinical outcomesWinston Wong, Maeve A Lowery, Michael F Berger, et al.
Nature Communications|November 23, 2022
Reversion mutations in germline BRCA1/2-mutant tumors reveal a BRCA-mediated phenotype in non-canonical histologiesYonina R Murciano-Goroff, Alison M Schram, Ezra Y Rosen, et al.
Breast Cancer Research and Treatment|January 23, 2022
Perceptions of patients and medical oncologists toward biospecimen donation in the setting of abnormal breast imaging findingsDavinia S Seah, Nabihah Tayob, Jose Pablo Leone, et al.
NPJ Precision Oncology|January 2, 2023
Expanded genetic testing of GIST patients identifies high proportion of non-syndromic patients with germline alterationsDiana Mandelker, Antonio Marra, Nikita Mehta, et al.
Cancer Research|January 16, 2019
Colorectal Carcinomas Containing Hypermethylated MLH1 Promoter and Wild-Type BRAF/KRAS Are Enriched for Targetable Kinase FusionsEmiliano Cocco, Jamal Benhamida, Sumit Middha, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 6, 2019
Meeting report from the joint IARC-NCI international cancer seminar series: a focus on colorectal cancerM J Gunter, S Alhomoud, M Arnold, et al.
Pageof 23

Showing results (121-130 of 229) with videos related to

Sort By:
Pageof 23
Journal of the National Comprehensive Cancer Network : JNCCN|April 11, 2014
Neoadjuvant chemotherapy first, followed by chemoradiation and then surgery, in the management of locally advanced rectal cancerAndrea Cercek, Karyn A Goodman, Carla Hajj, et al.
The American Journal of Gastroenterology|February 27, 2025
Neoplasia Detection Through Colonic Surveillance Among Young Individuals With MSH6 / PMS2 -Associated Lynch SyndromeAlicia Latham, Ying L Liu, Gillain Constantino, et al.
Familial Cancer|October 10, 2024
MSH6-proficient crypt foci in MSH6 constitutional mismatch repair deficiency: reversion of a frameshifted coding microsatellite to its wild-type sequenceJinru Shia, Francisco Sanchez-Vega, Stanley Cho, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 8, 2018
Determining the clinical validity of hereditary colorectal cancer and polyposis susceptibility genes using the Clinical Genome Resource Clinical Validity FrameworkBryce A Seifert, Jennifer L McGlaughon, Sarah A Jackson, et al.
Cancer|January 9, 2019
Ampullary cancer: Evaluation of somatic and germline genetic alterations and association with clinical outcomesWinston Wong, Maeve A Lowery, Michael F Berger, et al.
Nature Communications|November 23, 2022
Reversion mutations in germline BRCA1/2-mutant tumors reveal a BRCA-mediated phenotype in non-canonical histologiesYonina R Murciano-Goroff, Alison M Schram, Ezra Y Rosen, et al.
Breast Cancer Research and Treatment|January 23, 2022
Perceptions of patients and medical oncologists toward biospecimen donation in the setting of abnormal breast imaging findingsDavinia S Seah, Nabihah Tayob, Jose Pablo Leone, et al.
NPJ Precision Oncology|January 2, 2023
Expanded genetic testing of GIST patients identifies high proportion of non-syndromic patients with germline alterationsDiana Mandelker, Antonio Marra, Nikita Mehta, et al.
Cancer Research|January 16, 2019
Colorectal Carcinomas Containing Hypermethylated MLH1 Promoter and Wild-Type BRAF/KRAS Are Enriched for Targetable Kinase FusionsEmiliano Cocco, Jamal Benhamida, Sumit Middha, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 6, 2019
Meeting report from the joint IARC-NCI international cancer seminar series: a focus on colorectal cancerM J Gunter, S Alhomoud, M Arnold, et al.
Pageof 23